+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Meningococcal Vaccines Market Research Report by Type (Combination Vaccines, Conjugate Vaccines, and Men B Vaccines), Category, Dosage Type, End User, Target Group, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

  • PDF Icon

    Report

  • 259 Pages
  • July 2022
  • Region: Global
  • 360iResearch™
  • ID: 4857895
UP TO OFF until Mar 31st 2023
The Global Meningococcal Vaccines Market size was estimated at USD 5,027.78 million in 2022, USD 5,453.78 million in 2023, and is projected to grow at a CAGR of 10.24% to reach USD 10,972.72 million by 2030.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the Global Meningococcal Vaccines Market.

Cumulative Impact of Russia-Ukraine Conflict:

The publisher continuously monitors and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people’s lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the Global Meningococcal Vaccines Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The Global Meningococcal Vaccines Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the Global Meningococcal Vaccines Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. The market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for the market plan. This research report categorizes the Global Meningococcal Vaccines Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Type, the market is studied across Combination Vaccines, Conjugate Vaccines, Men B Vaccines, and Polysaccharide Vaccines. The Combination Vaccines is is further studied across MenHibrix and Menitorix. The Conjugate Vaccines is is further studied across Menactra, MenAfriVac, Meningitec, Menjugate, Menveo, NeisVac-C, Nimenrix, and NmVac4-DT. The Men B Vaccines is is further studied across Bexsero and Trumenba. The Polysaccharide Vaccines is is further studied across Mencevax, Menomune, and NmVac4.
  • Based on Category, the market is studied across Intramuscular and Subcutaneous.
  • Based on Dosage Type, the market is studied across Booster Vaccination and Primary Vaccination.
  • Based on End User, the market is studied across Hospital Pharmacies, Pediatric Clinic, and Retail Pharmacies.
  • Based on Target Group, the market is studied across Adult, Preteen, and Teenager.
  • Based on Region, the market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is is further studied across California, Connecticut, Florida, Illinois, Maryland, Minnesota, New Jersey, New York, Ohio, Pennsylvania, Texas, and Washington. The Asia-Pacific is is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the Global Meningococcal Vaccines Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The Global Meningococcal Vaccines Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The Global Meningococcal Vaccines Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The Global Meningococcal Vaccines Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor’s strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Meningococcal Vaccines Market, including Astellas Pharma Inc., AstraZeneca PLC, Bio-Manguinhos, Bio-Med (P) Limited, CanSino Biologics Inc., Chongqing Zhifei Biological Products Co., Ltd., GlaxoSmithKline PLC, Incepta Pharmaceuticals Ltd., Merck & Co., Inc., Mitsubishi Tanabe Pharma Corporation, Nanolek, LLC, Novartis AG, Petrovax Pharm, Pfizer Inc., Sanofi S.A., Serum Institute of India Pvt. Ltd., Taj Pharmaceuticals Limited, and Walvax Biotechnology Co., Ltd..

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Meningococcal Vaccines Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Meningococcal Vaccines Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Meningococcal Vaccines Market?
4. What is the competitive strategic window for opportunities in the Global Meningococcal Vaccines Market?
5. What are the technology trends and regulatory frameworks in the Global Meningococcal Vaccines Market?
6. What is the market share of the leading vendors in the Global Meningococcal Vaccines Market?
7. What modes and strategic moves are considered suitable for entering the Global Meningococcal Vaccines Market?
Frequently Asked Questions about the Global Meningococcal Vaccines Market

What is the estimated value of the Global Meningococcal Vaccines Market?

The Global Meningococcal Vaccines Market was estimated to be valued at $5027.78 Million in 2022.

What is the growth rate of the Global Meningococcal Vaccines Market?

The growth rate of the Global Meningococcal Vaccines Market is 10.2%, with an estimated value of $10972.72 Million by 2030.

What is the forecasted size of the Global Meningococcal Vaccines Market?

The Global Meningococcal Vaccines Market is estimated to be worth $10972.72 Million by 2030.

Who are the key companies in the Global Meningococcal Vaccines Market?

Key companies in the Global Meningococcal Vaccines Market include Astellas Pharma Inc., AstraZeneca PLC, Bio, Manguinhos, Bio, Med (P) Limited, CanSino Biologics Inc., Chongqing Zhifei Biological Products Co., Ltd. and Incepta Pharmaceuticals Ltd..

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing Incidence of Meningitis Across the World
5.1.1.2. Rising R&D Activities and Vaccines Developments in the Pipeline
5.1.1.3. Rising Immunization Programs and Government Initiatives for Meningococcal Diseases
5.1.2. Restraints
5.1.2.1. High Cost of Meningococcal Vaccines Production
5.1.3. Opportunities
5.1.3.1. Incidence of Bacterial Meningitis in Emerging Countries Coupled with Improvement in Surveillance System
5.1.3.2. Elevation of Collaborations and Partnerships to Support the Development of the Vaccines
5.1.4. Challenges
5.1.4.1. Limitations and Side Effects Associated with Meningococcal Vaccines
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of Russia-Ukraine Conflict
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Threat of Substitutes
5.5.4. Threat of Substitutes
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
5.8. Client Customization

6. Meningococcal Vaccines Market, by Type
6.1. Introduction
6.2. Combination Vaccines
6.3.1. MenHibrix
6.3.2. Menitorix
6.3. Conjugate Vaccines
6.4.1. Menactra
6.4.2. MenAfriVac
6.4.3. Meningitec
6.4.4. Menjugate
6.4.5. Menveo
6.4.6. NeisVac-C
6.4.7. Nimenrix
6.4.8. NmVac4-DT
6.4. Men B Vaccines
6.5.1. Bexsero
6.5.2. Trumenba
6.5. Polysaccharide Vaccines
6.6.1. Mencevax
6.6.2. Menomune
6.6.3. NmVac4

7. Meningococcal Vaccines Market, by Category
7.1. Introduction
7.2. Intramuscular
7.3. Subcutaneous

8. Meningococcal Vaccines Market, by Dosage Type
8.1. Introduction
8.2. Booster Vaccination
8.3. Primary Vaccination

9. Meningococcal Vaccines Market, by End User
9.1. Introduction
9.2. Hospital Pharmacies
9.3. Pediatric Clinic
9.4. Retail Pharmacies

10. Meningococcal Vaccines Market, by Target Group
10.1. Introduction
10.2. Adult
10.3. Preteen
10.4. Teenager

11. Americas Meningococcal Vaccines Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Meningococcal Vaccines Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Meningococcal Vaccines Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.1.1. Quadrants
14.1.2. Business Strategy
14.1.3. Product Satisfaction
14.2. Market Ranking Analysis, By Key Player
14.3. Market Share Analysis, By Key Player
14.4. Product Portfolio Analysis, By Key Player
14.5. Competitive Scenario
14.5.1. Merger & Acquisition
14.5.2. Agreement, Collaboration, & Partnership
14.5.3. New Product Launch & Enhancement
14.5.4. Investment & Funding
14.5.5. Award, Recognition, & Expansion

15. Company Usability Profiles
15.1. Astellas Pharma Inc.
15.2. AstraZeneca PLC
15.3. Bio-Manguinhos
15.4. Bio-Med (P) Limited
15.5. CanSino Biologics Inc.
15.6. Chongqing Zhifei Biological Products Co., Ltd.
15.7. GlaxoSmithKline PLC
15.8. Incepta Pharmaceuticals Ltd.
15.9. Merck & Co., Inc.
15.10. Mitsubishi Tanabe Pharma Corporation
15.11. Nanolek, LLC
15.12. Novartis AG
15.13. Petrovax Pharm
15.14. Pfizer Inc.
15.15. Sanofi S.A.
15.16. Serum Institute of India Pvt. Ltd.
15.17. Taj Pharmaceuticals Limited
15.18. Walvax Biotechnology Co., Ltd.

16. Appendix
16.1. Discussion Guide
16.2. License & Pricing


List of Figures
FIGURE 1. GLOBAL MENINGOCOCCAL VACCINES MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, 2022 VS 2030
FIGURE 3. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL MENINGOCOCCAL VACCINES MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2030
FIGURE 7. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 8. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MENINGOCOCCAL VACCINES MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 10. GLOBAL MENINGOCOCCAL VACCINES MARKET DYNAMICS
FIGURE 11. GLOBAL MENINGOCOCCAL VACCINES MARKET PORTER’S FIVE FORCES ANALYSIS
FIGURE 12. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
FIGURE 13. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL MENINGOCOCCAL VACCINES MARKET COMPETITIVE STRATEGIC WINDOW, BY TYPE, 2030
FIGURE 15. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2018-2030 (USD MILLION)
FIGURE 16. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENHIBRIX, 2018-2030 (USD MILLION)
FIGURE 17. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENITORIX, 2018-2030 (USD MILLION)
FIGURE 18. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2018-2030 (USD MILLION)
FIGURE 19. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENACTRA, 2018-2030 (USD MILLION)
FIGURE 20. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENAFRIVAC, 2018-2030 (USD MILLION)
FIGURE 21. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENINGITEC, 2018-2030 (USD MILLION)
FIGURE 22. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENJUGATE, 2018-2030 (USD MILLION)
FIGURE 23. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENVEO, 2018-2030 (USD MILLION)
FIGURE 24. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY NEISVAC-C, 2018-2030 (USD MILLION)
FIGURE 25. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY NIMENRIX, 2018-2030 (USD MILLION)
FIGURE 26. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY NMVAC4-DT, 2018-2030 (USD MILLION)
FIGURE 27. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2018-2030 (USD MILLION)
FIGURE 28. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY BEXSERO, 2018-2030 (USD MILLION)
FIGURE 29. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY TRUMENBA, 2018-2030 (USD MILLION)
FIGURE 30. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2018-2030 (USD MILLION)
FIGURE 31. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENCEVAX, 2018-2030 (USD MILLION)
FIGURE 32. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENOMUNE, 2018-2030 (USD MILLION)
FIGURE 33. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY NMVAC4, 2018-2030 (USD MILLION)
FIGURE 34. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2022 VS 2030 (%)
FIGURE 35. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 36. GLOBAL MENINGOCOCCAL VACCINES MARKET COMPETITIVE STRATEGIC WINDOW, BY CATEGORY, 2030
FIGURE 37. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY INTRAMUSCULAR, 2018-2030 (USD MILLION)
FIGURE 38. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY SUBCUTANEOUS, 2018-2030 (USD MILLION)
FIGURE 39. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2022 VS 2030 (%)
FIGURE 40. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 41. GLOBAL MENINGOCOCCAL VACCINES MARKET COMPETITIVE STRATEGIC WINDOW, BY DOSAGE TYPE, 2030
FIGURE 42. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY BOOSTER VACCINATION, 2018-2030 (USD MILLION)
FIGURE 43. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY PRIMARY VACCINATION, 2018-2030 (USD MILLION)
FIGURE 44. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2022 VS 2030 (%)
FIGURE 45. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 46. GLOBAL MENINGOCOCCAL VACCINES MARKET COMPETITIVE STRATEGIC WINDOW, BY END USER, 2030
FIGURE 47. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
FIGURE 48. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY PEDIATRIC CLINIC, 2018-2030 (USD MILLION)
FIGURE 49. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
FIGURE 50. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2022 VS 2030 (%)
FIGURE 51. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 52. GLOBAL MENINGOCOCCAL VACCINES MARKET COMPETITIVE STRATEGIC WINDOW, BY TARGET GROUP, 2030
FIGURE 53. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
FIGURE 54. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY PRETEEN, 2018-2030 (USD MILLION)
FIGURE 55. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY TEENAGER, 2018-2030 (USD MILLION)
FIGURE 56. AMERICAS MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 57. AMERICAS MENINGOCOCCAL VACCINES MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 58. AMERICAS MENINGOCOCCAL VACCINES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 59. AMERICAS MENINGOCOCCAL VACCINES MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 60. ARGENTINA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 61. BRAZIL MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 62. CANADA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 63. MEXICO MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 64. UNITED STATES MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 65. UNITED STATES MENINGOCOCCAL VACCINES MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 66. UNITED STATES MENINGOCOCCAL VACCINES MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 67. UNITED STATES MENINGOCOCCAL VACCINES MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
FIGURE 68. ASIA-PACIFIC MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 69. ASIA-PACIFIC MENINGOCOCCAL VACCINES MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 70. ASIA-PACIFIC MENINGOCOCCAL VACCINES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 71. ASIA-PACIFIC MENINGOCOCCAL VACCINES MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 72. AUSTRALIA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 73. CHINA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 74. INDIA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 75. INDONESIA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 76. JAPAN MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 77. MALAYSIA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 78. PHILIPPINES MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 79. SINGAPORE MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 80. SOUTH KOREA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 81. TAIWAN MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 82. THAILAND MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 83. VIETNAM MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 84. EUROPE, MIDDLE EAST & AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 85. EUROPE, MIDDLE EAST & AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 86. EUROPE, MIDDLE EAST & AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 87. EUROPE, MIDDLE EAST & AFRICA MENINGOCOCCAL VACCINES MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 88. DENMARK MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 89. EGYPT MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 90. FINLAND MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 91. FRANCE MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 92. GERMANY MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 93. ISRAEL MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 94. ITALY MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 95. NETHERLANDS MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 96. NIGERIA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 97. NORWAY MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 98. POLAND MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 99. QATAR MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 100. RUSSIA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 101. SAUDI ARABIA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 102. SOUTH AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 103. SPAIN MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 104. SWEDEN MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 105. SWITZERLAND MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 106. TURKEY MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 107. UNITED ARAB EMIRATES MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 108. UNITED KINGDOM MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 109. GLOBAL MENINGOCOCCAL VACCINES MARKET: FPNV POSITIONING MATRIX, 2022
FIGURE 110. GLOBAL MENINGOCOCCAL VACCINES MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 111. GLOBAL MENINGOCOCCAL VACCINES MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022


List of Tables
TABLE 1. GLOBAL MENINGOCOCCAL VACCINES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENHIBRIX, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENHIBRIX, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENHIBRIX, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENITORIX, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENITORIX, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENITORIX, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENACTRA, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENACTRA, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENACTRA, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENAFRIVAC, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENAFRIVAC, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENAFRIVAC, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENINGITEC, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENINGITEC, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENINGITEC, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENJUGATE, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENJUGATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENJUGATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENVEO, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENVEO, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENVEO, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY NEISVAC-C, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY NEISVAC-C, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY NEISVAC-C, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY NIMENRIX, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY NIMENRIX, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY NIMENRIX, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY NMVAC4-DT, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY NMVAC4-DT, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY NMVAC4-DT, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY BEXSERO, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY BEXSERO, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY BEXSERO, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY TRUMENBA, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY TRUMENBA, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY TRUMENBA, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENCEVAX, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENCEVAX, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENCEVAX, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENOMUNE, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENOMUNE, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENOMUNE, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY NMVAC4, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY NMVAC4, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY NMVAC4, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY INTRAMUSCULAR, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY SUBCUTANEOUS, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY BOOSTER VACCINATION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY BOOSTER VACCINATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY BOOSTER VACCINATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY PRIMARY VACCINATION, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY PRIMARY VACCINATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY PRIMARY VACCINATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY PEDIATRIC CLINIC, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY PEDIATRIC CLINIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 84. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY PEDIATRIC CLINIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 85. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 86. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 87. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 88. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 89. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 90. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 91. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 92. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY PRETEEN, 2018-2030 (USD MILLION)
TABLE 93. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY PRETEEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 94. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY PRETEEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 95. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY TEENAGER, 2018-2030 (USD MILLION)
TABLE 96. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY TEENAGER, BY REGION, 2018-2030 (USD MILLION)
TABLE 97. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY TEENAGER, BY REGION, 2018-2030 (USD MILLION)
TABLE 98. AMERICAS MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 99. AMERICAS MENINGOCOCCAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 100. AMERICAS MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 101. AMERICAS MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 102. AMERICAS MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 103. AMERICAS MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 104. AMERICAS MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 117. CANADA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 118. CANADA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 119. CANADA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 120. CANADA MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 121. CANADA MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 122. CANADA MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 123. MEXICO MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 124. MEXICO MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 125. MEXICO MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 126. MEXICO MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 127. MEXICO MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 128. MEXICO MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 129. UNITED STATES MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 130. UNITED STATES MENINGOCOCCAL VACCINES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 131. UNITED STATES MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 132. UNITED STATES MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 133. UNITED STATES MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 134. UNITED STATES MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 135. UNITED STATES MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 136. ASIA-PACIFIC MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 137. ASIA-PACIFIC MENINGOCOCCAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 138. ASIA-PACIFIC MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 139. ASIA-PACIFIC MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 140. ASIA-PACIFIC MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 141. ASIA-PACIFIC MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. ASIA-PACIFIC MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 143. AUSTRALIA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 144. AUSTRALIA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 145. AUSTRALIA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 146. AUSTRALIA MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 147. AUSTRALIA MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 148. AUSTRALIA MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 149. CHINA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 150. CHINA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 151. CHINA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 152. CHINA MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 153. CHINA MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 154. CHINA MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 155. INDIA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 156. INDIA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 157. INDIA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 158. INDIA MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 159. INDIA MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 160. INDIA MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 161. INDONESIA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 162. INDONESIA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 163. INDONESIA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 164. INDONESIA MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 165. INDONESIA MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 166. INDONESIA MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 167. JAPAN MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 168. JAPAN MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 169. JAPAN MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 170. JAPAN MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 171. JAPAN MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. JAPAN MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 173. MALAYSIA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 174. MALAYSIA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 175. MALAYSIA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 176. MALAYSIA MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 177. MALAYSIA MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 178. MALAYSIA MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 179. PHILIPPINES MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 180. PHILIPPINES MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 181. PHILIPPINES MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 182. PHILIPPINES MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 183. PHILIPPINES MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 184. PHILIPPINES MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 185. SINGAPORE MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 186. SINGAPORE MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 187. SINGAPORE MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 188. SINGAPORE MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 189. SINGAPORE MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 190. SINGAPORE MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 191. SOUTH KOREA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 192. SOUTH KOREA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 193. SOUTH KOREA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 194. SOUTH KOREA MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 195. SOUTH KOREA MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 196. SOUTH KOREA MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 197. TAIWAN MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 198. TAIWAN MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 199. TAIWAN MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 200. TAIWAN MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 201. TAIWAN MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 202. TAIWAN MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 203. THAILAND MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 204. THAILAND MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 205. THAILAND MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 206. THAILAND MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 207. THAILAND MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 208. THAILAND MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 209. VIETNAM MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 210. VIETNAM MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 211. VIETNAM MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 212. VIETNAM MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 213. VIETNAM MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 214. VIETNAM MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 222. DENMARK MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 223. DENMARK MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 224. DENMARK MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 225. DENMARK MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 226. DENMARK MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 227. DENMARK MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 228. EGYPT MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 229. EGYPT MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 230. EGYPT MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 231. EGYPT MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 232. EGYPT MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 233. EGYPT MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 234. FINLAND MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 235. FINLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 236. FINLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 237. FINLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 238. FINLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 239. FINLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 240. FRANCE MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 241. FRANCE MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 242. FRANCE MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 243. FRANCE MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 244. FRANCE MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 245. FRANCE MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 246. GERMANY MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 247. GERMANY MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 248. GERMANY MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 249. GERMANY MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 250. GERMANY MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 251. GERMANY MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 252. ISRAEL MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 253. ISRAEL MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 254. ISRAEL MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 255. ISRAEL MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 256. ISRAEL MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 257. ISRAEL MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 258. ITALY MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 259. ITALY MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 260. ITALY MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 261. ITALY MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 262. ITALY MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 263. ITALY MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 264. NETHERLANDS MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 265. NETHERLANDS MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 266. NETHERLANDS MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 267. NETHERLANDS MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 268. NETHERLANDS MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 269. NETHERLANDS MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 270. NIGERIA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 271. NIGERIA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 272. NIGERIA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 273. NIGERIA MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 274. NIGERIA MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 275. NIGERIA MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 276. NORWAY MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 277. NORWAY MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 278. NORWAY MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 279. NORWAY MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 280. NORWAY MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 281. NORWAY MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 282. POLAND MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 283. POLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 284. POLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 285. POLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 286. POLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 287. POLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 288. QATAR MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 289. QATAR MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 290. QATAR MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 291. QATAR MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 292. QATAR MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 293. QATAR MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 294. RUSSIA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 295. RUSSIA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 296. RUSSIA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 297. RUSSIA MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 298. RUSSIA MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 299. RUSSIA MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 300. SAUDI ARABIA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 301. SAUDI ARABIA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 302. SAUDI ARABIA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 303. SAUDI ARABIA MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 304. SAUDI ARABIA MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 306. SOUTH AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 307. SOUTH AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 308. SOUTH AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 309. SOUTH AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 310. SOUTH AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 311. SOUTH AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 312. SPAIN MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 313. SPAIN MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 314. SPAIN MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 315. SPAIN MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 316. SPAIN MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 317. SPAIN MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 318. SWEDEN MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 319. SWEDEN MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 320. SWEDEN MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 321. SWEDEN MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 322. SWEDEN MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 323. SWEDEN MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 324. SWITZERLAND MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 325. SWITZERLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 326. SWITZERLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 327. SWITZERLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 328. SWITZERLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 329. SWITZERLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 330. TURKEY MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 331. TURKEY MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 332. TURKEY MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 333. TURKEY MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 334. TURKEY MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 335. TURKEY MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 336. UNITED ARAB EMIRATES MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 337. UNITED ARAB EMIRATES MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 338. UNITED ARAB EMIRATES MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 339. UNITED ARAB EMIRATES MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 340. UNITED ARAB EMIRATES MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 341. UNITED ARAB EMIRATES MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 342. UNITED KINGDOM MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 343. UNITED KINGDOM MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 344. UNITED KINGDOM MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 345. UNITED KINGDOM MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 346. UNITED KINGDOM MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 347. UNITED KINGDOM MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 348. GLOBAL MENINGOCOCCAL VACCINES MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
TABLE 349. GLOBAL MENINGOCOCCAL VACCINES MARKET: FPNV POSITIONING MATRIX - BUSI

Companies Mentioned

  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Bio-Manguinhos
  • Bio-Med (P) Limited
  • CanSino Biologics Inc.
  • Chongqing Zhifei Biological Products Co., Ltd.
  • GlaxoSmithKline PLC
  • Incepta Pharmaceuticals Ltd.
  • Merck & Co., Inc.
  • Mitsubishi Tanabe Pharma Corporation
  • Nanolek, LLC
  • Novartis AG
  • Petrovax Pharm
  • Pfizer Inc.
  • Sanofi S.A.
  • Serum Institute of India Pvt. Ltd.
  • Taj Pharmaceuticals Limited
  • Walvax Biotechnology Co., Ltd.

Methodology

Loading
LOADING...